Generally, individuals assigned female at birth (AFAB) develop greater immunogenicity to various vaccines than individuals assigned male at birth (AMAB).
Little is known about sex-disaggregated immunogenicity to HIV-1 vaccines.
We disaggregated immune responses to an experimental HIV vaccine regimen.
